Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response
Background: A pair of genes is defined as synthetically lethal if defects on both cause the death of the cell but a defect in only one of the two is compatible with cell viability. Ideally, if A and B are two synthetic lethal genes, inhibiting B should kill cancer cells with a defect on A, and shoul...
Main Authors: | Ceri, S. (Author), Pinoli, P. (Author), Srihari, S. (Author), Wong, L. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response
by: Pietro Pinoli, et al.
Published: (2021-05-01) -
RAD52 as a Potential Target for Synthetic Lethality-Based Anticancer Therapies
by: Monika Toma, et al.
Published: (2019-10-01) -
Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer
by: Tommi Rantapero, et al.
Published: (2020-03-01) -
Genomic Determinants of Homologous Recombination Deficiency across Human Cancers
by: Tao Qing, et al.
Published: (2021-09-01) -
Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
by: Yitzhak Zimmer, et al.
Published: (2020-10-01)